Hantz Financial Services’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 2045 |
|
|
2025
Q1 | $1K | Hold |
350
| – | – | ﹤0.01% | 1450 |
|
|
2024
Q4 | $1K | Hold |
350
| – | – | ﹤0.01% | 1011 |
|
|
2024
Q3 | $1K | Hold |
350
| – | – | ﹤0.01% | 993 |
|
|
2024
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 981 |
|
|
2024
Q1 | $1K | Hold |
350
| – | – | ﹤0.01% | 1094 |
|
|
2023
Q4 | $1K | Hold |
350
| – | – | ﹤0.01% | 1055 |
|
|
2023
Q3 | $1K | Hold |
350
| – | – | ﹤0.01% | 1049 |
|
|
2023
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 1014 |
|
|
2023
Q1 | $1K | Hold |
350
| – | – | ﹤0.01% | 1031 |
|
|
2022
Q4 | $1K | Hold |
350
| – | – | ﹤0.01% | 998 |
|
|
2022
Q3 | $1K | Hold |
350
| – | – | ﹤0.01% | 995 |
|
|
2022
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 973 |
|
|
2022
Q1 | $1K | Buy |
+350
| New | +$1K | ﹤0.01% | 978 |
|